Clearance Summary
EIA SMDP IMMUNOASSAY received FDA 510(k) clearance under submission number K132631, sponsored by Phadia US, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2014-08-29.
- Submission: K132631
- Applicant / Sponsor: Phadia US, Inc.
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5100
- Decision date: 2014-08-29
Classification & Regulation
This clearance is catalogued under FDA product code LKP and 21 CFR 866.5100, within the Immunology review panel as a Class II device.